Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada.

Source:http://linkedlifedata.com/resource/pubmed/id/2820289

Download in:

View as

General Info

PMID
2820289